Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis-Reference-Cited by-同舟云学术

Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis

Published:2024-05-20 Issue:8 Volume:35 Page:1134-1135
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Hung Kuo-Chin¹²^ORCID,Chao Chia-Ter²³⁴^ORCID

Affiliation:

1. Department of Pharmacy, Tajen University, Pingtung, Taiwan

2. Division of Nephrology, Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan City, Taiwan

3. Neprology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

4. Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan

Funder

National Taiwan University Hospital

National Science and Technology Council

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference4 articles.

1. Ondansetron and the risk of sudden cardiac death among individuals receiving maintenance hemodialysis;Ismail;J Am Soc Nephrol.,2024

2. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans;Dixon;Drug Metab Dispos,1995

3. Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P450 1A enzymes;Shivanna;J Pharmacol Exp Ther.,2011

4. Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients;Anand;BMC Geriatr.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis;Journal of the American Society of Nephrology;2024-05-20